GILD

127.75

2.05% -2.65

시간 외 거래: 127.90 0.15 +0.12%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$130.40

열려 있는:

$128.8

하루 거래량:

8.04M

Relative Volume:

1.19

시가총액:

$158.56B

수익:

$29.45B

순이익/손실:

$8.51B

주가수익비율:

18.84

EPS:

6.7823

순현금흐름:

$9.46B

1주 성능:

-5.99%

1개월 성능:

-4.86%

6개월 성능:

+6.03%

1년 성능:

+23.81%

1일 변동 폭

$127.64

$130.33

1주일 범위

$127.64

$136.34

52주 변동 폭

$95.30

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1111)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-05-07

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, AZN, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	127.75	161.85B	29.45B	8.51B	9.46B	6.7823
LLY Lilly Eli Co	868.27	789.69B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	225.34	547.64B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	197.38	351.47B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	187.51	294.27B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	144.19	277.58B	54.72B	14.02B	15.32B	7.1855

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

02:53 AM

Gilead Sciences (GILD) Builds Defensive Moat With HIV Franchise Ahead of May 7 Earnings - AlphaStreet

02:53 AM

07:08 AM

Pictet Asset Management Holding SA Sells 326,886 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

07:08 AM

06:52 AM

State of Michigan Retirement System Sells 10,800 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

06:52 AM

06:26 AM

Sanctuary Advisors LLC Has $27.19 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

06:26 AM

05:36 AM

Mag 7 Earnings Bonanza, Fed Await Stocks at Record Highs: What to Expect - Investing.com

05:36 AM

05:06 AM

Gilead Sciences Obtains Regulatory Approval for Arcellx Acquisition - HarianBasis.co

05:06 AM

02:11 AM

Gilead Sciences (GILD) Set to Acquire Arcellx - Insider Monkey

02:11 AM

Apr 26, 2026

A Look At Kymera Therapeutics (KYMR) Valuation After Fast Track News And Gilead Collaboration Progress - Yahoo Finance

Apr 26, 2026

Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock - Yahoo Finance

Apr 26, 2026

Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN

Apr 26, 2026

Vanguard Group Inc. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 26, 2026

Concurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 26, 2026

Axecap Investments LLC Has $3.43 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 26, 2026

AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 26, 2026

Apr 25, 2026

Impax Asset Management Group plc Acquires 19,894 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 25, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Polaris Capital Management LLC - MarketBeat

Apr 25, 2026

Gilead Sciences Inc (NASDAQ:GILD): A Balanced Dividend Play with Strong Financial Health and Profitability - ChartMill

Apr 25, 2026

Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 25, 2026

Apr 24, 2026

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts - Yahoo Finance Australia

Apr 24, 2026

Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 24, 2026

Gilead’s Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD - Yahoo Finance

Apr 24, 2026

NBC Securities Inc. Acquires 10,296 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 24, 2026

Gilead Sciences, Inc. $GILD is Kerusso Capital Management LLC's 6th Largest Position - MarketBeat

Apr 24, 2026

Teacher Retirement System of Texas Sells 33,061 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 24, 2026

Gilead Sciences, Inc. $GILD Stake Boosted by China Universal Asset Management Co. Ltd. - MarketBeat

Apr 24, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Arizona State Retirement System - MarketBeat

Apr 24, 2026

Gilead Sciences to buy clinical-stage biotech Tubulis for up to $5 billion - MSN

Apr 24, 2026

GILD Stock Price, Quote & Chart | GILEAD SCIENCES INC (NASDAQ:GILD) - ChartMill

Apr 24, 2026

Apr 23, 2026

Transforming What’s Next, Now: Gilead’s 2025 Responsible Business and Impact Report - Gilead Sciences

Apr 23, 2026

Gilead Sciences (GILD) Ends Losing Streak with 0.56% Gain - GuruFocus

Apr 23, 2026

Gilead Sciences nears $2B deal for Ouro MedicinesFT - MSN

Apr 23, 2026

Milestone Asset Management LLC Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 23, 2026

Gilead Sciences: Core HIV and Liver Franchises Drive EPS Upside and Support Buy Rating Despite Cell Therapy Headwinds - TipRanks

Apr 23, 2026

GILD (Gilead Sciences Inc.) reports narrow Q4 2025 earnings beat and mild revenue growth, shares dip slightly.Mature Phase - Xã Thanh Hà

Apr 23, 2026

Gilead Sciences, Inc. $GILD Holdings Decreased by Ruffer LLP - MarketBeat

Apr 23, 2026

Caprock Group LLC Buys 12,895 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 23, 2026

B. Metzler seel. Sohn & Co. AG Acquires 17,584 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Apr 23, 2026

Apr 22, 2026

Gilead Sciences Inc. (GILD) Announces Q1 2026 Earnings Release Date, Signaling Near-Term Upside CatalystSurprise Factor - Xã Thanh Hà

Apr 22, 2026

FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral - MedCity News

Apr 22, 2026

Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 - Business Wire

Apr 22, 2026

Gilead Sciences stock price forecast: limited upside as GILD trades near support after weekly decline - Traders Union

Apr 22, 2026

Gilead set to report as Yeztugo launch, M&A strategy face test - Investing.com

Apr 22, 2026

Universal Beteiligungs und Servicegesellschaft mbH Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat

Apr 22, 2026

Merck steps up as ‘meaningful competitor’ to Gilead with HIV pill approval - BioSpace

Apr 22, 2026

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness And Long Term Gains - simplywall.st

Apr 22, 2026

Apr 21, 2026

Gilead Sciences Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 21, 2026

Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - Yahoo Finance

Apr 21, 2026

Release of 2025 impact report weighs on Gilead Sciences stock amid oversold momentum signals - Traders Union

Apr 21, 2026

Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026? - TIKR.com

Apr 21, 2026

7,568 Shares in Gilead Sciences, Inc. $GILD Acquired by Ticino Wealth - MarketBeat

Apr 21, 2026

Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls - BioSpace

Apr 21, 2026